ID
45329
Beschreibung
Principal Investigator: Matthew Meyerson, MD, PhD, Dana Farber Cancer Institute, Boston MA MeSH: Solitary Fibrous Tumors https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000568 Solitary fibrous tumors (SFTs) are rare mesenchymal tumors that can be benign or malignant. In this study, we sequenced and analyzed the exomes of 17 SFT matched tumor and normal pairs. This study appertains to a large endeavor to characterize cancers as part of the Slim Initiative for Genomic Medicine in the Americas (SIGMA) project.
Link
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000568
Stichworte
Versionen (2)
- 31.10.22 31.10.22 - Simon Heim
- 13.12.22 13.12.22 - Kristina Keller
Rechteinhaber
Matthew Meyerson, MD, PhD, Dana Farber Cancer Institute, Boston MA
Hochgeladen am
31. Oktober 2022
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
dbGaP phs000568 Genomic Sequencing of Solitary Fibrous Tumors
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, subject source ID, consent group, and affection status of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable obtained from participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, age, sex, race, primary disease, and treatment received before surgery of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, primary tumor, metastasis, or transformed cell line, and samples obtained from tumor after some treatment and associated with participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, subject source ID, consent group, and affection status of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable obtained from participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, age, sex, race, primary disease, and treatment received before surgery of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, primary tumor, metastasis, or transformed cell line, and samples obtained from tumor after some treatment and associated with participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
C1266119 (UMLS CUI [1,2])
C5395609 (UMLS CUI [1,3])